Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Supernus Pharm (SUPN)

Supernus Pharm (SUPN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Supernus (SUPN) Seeks Label Expansion for ADHD Drug Qelbree

The FDA accepts Supernus' (SUPN) regulatory application seeking label application for Qelbree to include adult patients with ADHD.

JNJ : 164.75 (-0.28%)
RGEN : 306.90 (+2.34%)
SUPN : 27.28 (+0.33%)
TAK : 17.15 (-0.29%)
Novavax Appoints Biopharmaceutical Veterans Jim Kelly as Chief Financial Officer and Nasir Egal, Ph.D., as Senior Vice President of Quality Assurance

/PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company developing next-generation vaccines for serious infectious diseases, today announced the appointment of as Executive Vice President,...

SUPN : 27.28 (+0.33%)
NVAX : 237.54 (+0.11%)
Supernus Pharmaceuticals (SUPN) Beats Q2 Earnings and Revenue Estimates

Supernus (SUPN) delivered earnings and revenue surprises of 152.94% and 4.82%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

SUPN : 27.28 (+0.33%)
Supernus: Q2 Earnings Snapshot

ROCKVILLE, Md. (AP) _ Supernus Pharmaceuticals Inc. (SUPN) on Wednesday reported second-quarter profit of $23.7 million.

SUPN : 27.28 (+0.33%)
Supernus Announces Second Quarter 2021 Financial Results

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today reported...

SUPN : 27.28 (+0.33%)
Supernus to Host Second Quarter 2021 Financial Results Conference Call

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced...

SUPN : 27.28 (+0.33%)
RSI Alert: Supernus Pharmaceuticals (SUPN) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical...

SUPN : 27.28 (+0.33%)
Is First Trust Small Cap Value AlphaDEX ETF (FYT) a Strong ETF Right Now?

Smart Beta ETF report for FYT

FYT : 49.51 (-0.10%)
SUPN : 27.28 (+0.33%)
GHC : 585.29 (+0.79%)
TGNA : 19.58 (-0.51%)
VBR : 170.07 (-0.62%)
IWN : 160.30 (-0.09%)
Thinking about buying stock in Fisker, Torchlight Energy, Intec Pharma, Supernus Pharmaceuticals, or Cyclo Therapeutics?

/PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for FSR, TRCH, NTEC, SUPN, and CYTH.

CYTH : 6.81 (+3.03%)
SUPN : 27.28 (+0.33%)
NTEC : 9.63 (-12.48%)
TRCH : 4.95 (+4.21%)
FSR : 13.50 (+7.06%)
Supernus to Present at Jefferies Virtual Healthcare Conference

Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced...

SUPN : 27.28 (+0.33%)

Barchart Exclusives

Natural Gas- Higher Multi-Year Highs
Natural gas has been making higher lows over the past fifteen months. The energy commodity began making higher multi-year highs in June 2021. With the peak season for demand on the horizon, the price is trading above $5, a level not seen since February 2014. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar